Abstract
Purpose
Rikkunshito is a traditional Japanese medicine that is widely used for treating upper gastrointestinal symptoms. Our purpose is to clarify the effect of Rikkunshito on the levels of peptide hormones and cytokines in healthy humans and mice.
Methods
We administered Rikkunshito, 7.5 g per day, to 21 healthy volunteers for 2 weeks and examined the changes in plasma peptide and hormone levels. In mice, we administered free access to water containing 0, 0.7, 1.1, and 1.4% Rikkunshito for 2 weeks and examined the changes in plasma peptide levels and ghrelin mRNA expression levels in the stomach.
Results
Plasma acylated ghrelin levels at 0, 2, and 6 weeks after the start of administration were 6.7 ± 2.8, 11.7 ± 4.0, and 10.5 ± 4.4 fmol/ml, respectively. The levels at 2 and 6 weeks were significantly higher than that at 0 time (p < 0.01, paired t test). The levels of interleukin 4, interferon γ, and granulocyte colony-stimulating factor in plasma decreased significantly (p < 0.01) after the administration of Rikkunshito. In mice, the levels of plasma acylated ghrelin changed in proportion to the concentration of Rikkunshito in drinking water, and it was revealed by quantitative RT-PCR that the ghrelin mRNA expression level in the stomach was up-regulated.
Conclusion
Rikkunshito increased the plasma acylated ghrelin level in healthy volunteers and normal mice. Additionally, this change was maintained for at least 4 weeks after the end of administration. In mice, Rikkunshito increased the ghrelin mRNA expression level in the stomach.
Similar content being viewed by others
Abbreviations
- GH:
-
Growth hormone
- FD:
-
Functional dyspepsia
- GHRL:
-
Ghrelin prepropeptide
- GOAT:
-
Ghrelin o-acyltransferase
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
References
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.
Nakazato M, Murakami N, Kojima M, Matuo H, Kangawa K, Matsukura S, et al. A role of ghrelin in the central regulation of feeding. Nature. 2001;409:194–8.
Wren AM, Seal LJ, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.
Tack J, Depoortere I, Coulie B, Meulemans A, Janssens J, Peeters T, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut. 2006;55(3):327–33.
Strassburg S, Anker SD, Dong JZ, Culler MD, Datta R, Tschöp MH, et al. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am J Physiol Endocrinol Metab. 2008;295(1):E78–84.
Tatsuta M, Iishi H. Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther. 1993;7:459–62.
Tomono H, Ito Y, Watanabe T. Successful antiemetic treatment of Tsumura rikkunshi-to extract granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Jpn J Cancer Chemother. 2006;33:1129–31.
Oka T, Tamagawa Y, Tamagawa Y, Hayashida S, Kaneda Y, Kodama N, et al. Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med. 2007;15:1–21.
Takeda H, Sadakane C, Katsurada T, Ohkawara T, Nagai K, Asaka M, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134:2004–13.
Arai M, Yokosuka O, Takiguchi M, Saisho H, Muramatsu M, Seki N, et al. Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem. 2003;278:29813–8.
Arvat E, Gianotti L, Papotti M, Graziani A, Ghigo E, Deghenghi R, et al. Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system. Endocrine. 2001;14:35–43.
Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care. 2002;5:391–5.
Wolf I, Sadetzki S, Oberman B, Catane R, Kaufman B, Shimon I. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer. 2006;15(106):966–73.
Ataseven H, Bahcecioglu I, Yalniz M, Celebi S, Erensoy A, Ustundag B, et al. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm. 2006;2006:78380.
Shinomiya T, Fukunaga M, Yokode M, Kangawa K, Nakai Y, Nakai Y, et al. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol. 2005;40:648–53.
Garcia JM, Garcia-Touza M, Mann D, Smith RG, Cunningham GR, Marcelli M, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005;90:2920–6.
Soriano-Guillén L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr. 2004;144:36–42.
Dostálová V, Haluzík M. The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa. Physiol Res. 2008;58:159–70.
Takamori K, Mizuta Y, Ohba K, Omagari K, Shikuwa S, Kohno S, et al. Relation among plasma ghrelin level, gastric emptying, and psychological condition in patients with functional dyspepsia. J Clin Gastroenterol. 2007;41:477–83.
Pilichiewicz AN, Feltrin KL, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C, et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol. 2008;103(10):2613–23.
Akamizu T, Iwakura H, Fukunaga M, Nakai Y, Kangawa K, Clinical Study Team FD, et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol. 2008;158:491–8.
Shindo T, Futagami S, Hiratsuka T, Horie A, Hamamoto T, Ueki N, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion. 2009;79:65–72.
Ringel Y. Brain research in functional gastrointestinal disorders. J Clin Gastroenterol. 2002;35:23–5.
Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol. 2004;55:137–54.
Itoh Z. Motilin and clinical application. Peptides. 1997;18:593–608.
Sanger GJ. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov Today. 2008;13:234–9.
Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387–96.
Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006;130:1707–20.
Dixit VD, Schaffer EM, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114:57–66.
Zhang M, Yuan F, Chen H, Qiu X, Fang W. Effect of exogenous ghrelin on cell differentiation antigen 40 expression in endothelial cells. Acta Biochim Biophys Sin. 2007;39:974–81.
Kodama T, Ashitani J, Matsumoto N, Kangawa K, Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther. 2008;21:774–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsumura, T., Arai, M., Yonemitsu, Y. et al. The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol 45, 300–307 (2010). https://doi.org/10.1007/s00535-009-0166-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-009-0166-z